[Indomethacin and hematopoiesis. Antipyretic and antiphlogistic effects in hemoblastoses and various uncommon diseases].
D001170:Arthritis, Infectious / Q000188:drug therapy; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D003882:Dermatomyositis / Q000188:drug therapy; D005260:Female; D006402:Hematologic Diseases / Q000188:drug therapy*; D006410:Hematopoiesis / Q000187:drug effects*; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D007213:Indomethacin / Q000008:administration & dosage*; D007898:Leishmaniasis, Visceral / Q000188:drug therapy; D007938:Leukemia / Q000188:drug therapy; D007951:Leukemia, Myeloid / Q000188:drug therapy; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D008206:Lymphatic Diseases / Q000188:drug therapy; D008297:Male; D011087:Polycythemia Vera / Q000188:drug therapy; D011565:Psoriasis / Q000188:drug therapy; D012595:Scleroderma, Systemic / Q000188:drug therapy; D013921:Thrombocytopenia / Q000188:drug therapy
D007213:Indomethacin
Indometacin und Hämatopoese. Antipyretische und antiphlogistische Wirkung bei Hämoblastosen und einigen seltenen Krankheitsbildern.